|
US3340276A
(en)
|
1964-04-01 |
1967-09-05 |
Ciba Geigy Corp |
3, 4-diphenyl-chromans
|
|
DE1518002C3
(de)
|
1965-01-02 |
1975-01-23 |
Merck Patent Gmbh, 6100 Darmstadt |
Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel
|
|
DE1543749A1
(de)
|
1966-02-16 |
1969-12-11 |
Merck Ag E |
Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
|
|
GB1433013A
(OSRAM)
|
1973-06-08 |
1976-04-22 |
|
|
|
US4218489A
(en)
|
1977-06-08 |
1980-08-19 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4157984A
(en)
|
1977-06-08 |
1979-06-12 |
Z-L Limited |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4264509A
(en)
|
1977-06-08 |
1981-04-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4232122A
(en)
|
1979-01-17 |
1980-11-04 |
Z-L Limited Partnership |
Antioxidants, antioxidant compositions and methods of preparing and using same
|
|
US4234577A
(en)
|
1979-03-19 |
1980-11-18 |
Z-L Limited Partnership |
Ergostadientriols, compositions containing same, and methods of preparing and using same
|
|
US4368264A
(en)
|
1979-03-19 |
1983-01-11 |
Z-L Limited Partnership |
Fermentation methods of preparing ergostadientriols
|
|
US4366248A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Fermentation method of preparing antioxidants
|
|
US4366082A
(en)
|
1979-04-11 |
1982-12-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4390559A
(en)
|
1979-04-11 |
1983-06-28 |
Z-L Limited Partnership |
Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same
|
|
US4447622A
(en)
|
1981-09-22 |
1984-05-08 |
Council Of Scientific And Industrial Research Rafi Marg |
Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof
|
|
US4644012A
(en)
|
1983-12-21 |
1987-02-17 |
Takeda Chemical Industries, Ltd. |
Treatment for osteoporosis
|
|
GB8626344D0
(en)
|
1986-11-04 |
1986-12-03 |
Zyma Sa |
Bicyclic compounds
|
|
US5059609A
(en)
|
1987-10-19 |
1991-10-22 |
Pfizer Inc. |
Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
|
|
MX13485A
(es)
|
1987-10-19 |
1993-05-01 |
Pfizer |
Procedimiento para obtener tetralinas, cromados y compuestos relacionados, sustituidos
|
|
US5002935A
(en)
|
1987-12-30 |
1991-03-26 |
University Of Florida |
Improvements in redox systems for brain-targeted drug delivery
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
EP0470310B1
(en)
|
1990-08-09 |
1995-11-29 |
Council of Scientific and Industrial Research |
Novel benzopyrans and process for their production
|
|
KR950704291A
(ko)
|
1992-10-21 |
1995-11-17 |
알렌 제이. 스피겔 |
거울상 이성질체 시스-3-(4,6-디하이드록시크로만-3-일메틸)벤조산(enantiomeric cis-3-(4,6-dihydroxychroman-3-ylmethyl)benzoic acids)
|
|
US5451603A
(en)
|
1993-03-11 |
1995-09-19 |
Zymogenetics, Inc. |
3,4-diarylchromans for treatment of dermatitis
|
|
US5280040A
(en)
|
1993-03-11 |
1994-01-18 |
Zymogenetics, Inc. |
Methods for reducing bone loss using centchroman derivatives
|
|
US5389646A
(en)
|
1993-12-30 |
1995-02-14 |
Zymogenetics, Inc. |
Methods for treatment and prevention of bone loss using 2,3-benzopyrans
|
|
US5792776A
(en)
|
1994-06-27 |
1998-08-11 |
Cytomed, Inc., |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
|
CN1168098A
(zh)
|
1995-01-13 |
1997-12-17 |
诺沃挪第克公司 |
3,4-二苯基苯并二氢吡喃在生产用于治疗或预防高脂蛋白血症、高甘油三酯血症、高脂血症或高胆固醇血症或动脉硬化或用于抗凝治疗的药物组合物中的用途
|
|
HUP9702244A3
(en)
|
1995-01-13 |
1999-12-28 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
|
|
JPH10511960A
(ja)
|
1995-01-13 |
1998-11-17 |
ノボ ノルディスク アクティーゼルスカブ |
特発性の又は生理学的な女性化乳房の治療又は予防のための医薬製剤の製造のための３，４−ジフェニル・クロマンの使用
|
|
TW448046B
(en)
|
1995-01-20 |
2001-08-01 |
Novo Nordisk As |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
|
|
CN1168100A
(zh)
|
1995-01-20 |
1997-12-17 |
诺沃挪第克公司 |
3，4-二苯基苯并二氢吡喃制备治疗或预防血管舒张的药物组合物的用途
|
|
JPH10512269A
(ja)
|
1995-01-20 |
1998-11-24 |
ノボ ノルディスク アクティーゼルスカブ |
大脳の変性疾患の治療または予防用の医薬組成物の製造のための３，４−ジフェニルクロマンの使用
|
|
US5849461A
(en)
|
1995-08-01 |
1998-12-15 |
Shin-Etsu Chemical Co., Ltd. |
Chemically amplified positive resist composition
|
|
US5883118A
(en)
|
1996-01-11 |
1999-03-16 |
Nova Nordisk A/S |
Prostatic carcinoma
|
|
US5747059A
(en)
|
1996-01-11 |
1998-05-05 |
Novo Nordisk A/S |
Atrophy of skin/mucous membrane
|
|
US5726202A
(en)
|
1996-01-11 |
1998-03-10 |
Novo Nordisk A/S |
Benign prostatic hypertrophy
|
|
PL327831A1
(en)
|
1996-01-11 |
1999-01-04 |
Novo Nordisk As |
Application of 3,4-diphenylchromanes in production of a pharmaceutic agent for treating or preventing menopause symptoms
|
|
US5756539A
(en)
|
1996-07-11 |
1998-05-26 |
Novo Nordis A/S |
3, 4-diphenyl chromans for inhibiting one or more psychiatric disorders
|
|
WO1998002156A1
(en)
|
1996-07-12 |
1998-01-22 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure
|
|
WO1998002154A1
(en)
|
1996-07-12 |
1998-01-22 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
|
|
AUPO203996A0
(en)
|
1996-08-30 |
1996-09-26 |
Novogen Research Pty Ltd |
Therapeutic uses
|
|
GB9621757D0
(en)
|
1996-10-18 |
1996-12-11 |
Ciba Geigy Ag |
Phenyl-substituted bicyclic heterocyclyl derivatives and their use
|
|
US5919817A
(en)
|
1996-10-28 |
1999-07-06 |
Novo Nordisk A/S |
Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
IL129623A0
(en)
|
1996-10-28 |
2000-02-29 |
Novo Nordisk As |
Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ZA979644B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
|
US5958967A
(en)
|
1996-10-28 |
1999-09-28 |
Novo Nordisk A/S |
Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
JP2001502710A
(ja)
|
1996-10-28 |
2001-02-27 |
ノボ ノルディスク アクティーゼルスカブ |
エストロゲン関連疾患または症候群の予防または治療に有用な新規なシス―３，４―クロマン誘導体
|
|
US6043269A
(en)
|
1996-10-28 |
2000-03-28 |
Novo Nordisk A/S |
cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
EP0937056A1
(en)
|
1996-10-28 |
1999-08-25 |
Novo Nordisk A/S |
A process for the preparation of (-)-3,4-trans-diarylchromans
|
|
WO1998018773A1
(en)
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US5994390A
(en)
|
1996-10-28 |
1999-11-30 |
Novo Nordisk |
Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
ES2191170T3
(es)
|
1996-10-28 |
2003-09-01 |
Novo Nordisk As |
Nuevos (-)-enantiomeros de derivados de cis-3,4-cromano utiles en la prevencion y tratamiento de sindromes o enfermedades relacionadas con el estrogeno.
|
|
ZA979647B
(en)
|
1996-10-28 |
1998-04-28 |
Novo Nordisk As |
Heterocyclic compounds, compositions and uses.
|
|
ATE229519T1
(de)
|
1996-10-28 |
2002-12-15 |
Novo Nordisk As |
Neue cis-3,4-chromanderivate zur vorbeugung oder behandlung von oestrogenbezogenen krankheiten oder syndromen
|
|
US6316494B1
(en)
|
1996-10-28 |
2001-11-13 |
Novo Nordisk A/S |
cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
US5985306A
(en)
|
1996-10-28 |
1999-11-16 |
Novo Nordisk A/S |
(+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
|
|
CA2270057A1
(en)
|
1996-10-28 |
1998-05-07 |
Novo Nordisk A/S |
Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
|
|
CN1120162C
(zh)
|
1996-12-13 |
2003-09-03 |
中外制药株式会社 |
新的苯并吡喃衍生物
|
|
WO1998033500A1
(en)
|
1997-01-29 |
1998-08-06 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting senescence-associated motor impairment
|
|
WO1998032437A1
(en)
|
1997-01-29 |
1998-07-30 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
|
|
WO1998033499A1
(en)
|
1997-01-29 |
1998-08-06 |
Novo Nordisk A/S |
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for increasing libido in post-menopausal women
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
AUPP112497A0
(en)
|
1997-12-24 |
1998-01-22 |
Novogen Research Pty Ltd |
Compositions and method for protecting skin from UV induced immunosupression and skin damage
|
|
WO1999049862A1
(en)
|
1998-03-30 |
1999-10-07 |
The University Of Mississippi |
Isoflavones for treating giardiasis and malaria
|
|
AU3407799A
(en)
|
1998-04-28 |
1999-11-16 |
Novo Nordisk A/S |
Enzymatic resolvation for obtaining a (-)-3,4-trans-diarylchroman
|
|
FR2778404B1
(fr)
|
1998-05-06 |
2000-06-30 |
Hoechst Marion Roussel Inc |
Derives du dihydro ou tetrahydronaphtalene, et les compositions pharmaceutiques les renfermant
|
|
US6465445B1
(en)
|
1998-06-11 |
2002-10-15 |
Endorecherche, Inc. |
Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
|
|
KR20000001793A
(ko)
|
1998-06-13 |
2000-01-15 |
이경하 |
신규한 벤조피란 또는 티오벤조피란 유도체
|
|
US6509323B1
(en)
|
1998-07-01 |
2003-01-21 |
California Institute Of Technology |
Linear cyclodextrin copolymers
|
|
FR2789685B1
(fr)
|
1999-02-15 |
2001-05-04 |
Univ Lille Sciences Tech |
Procede de fabrication de polymeres solubles et insolubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s) et polymeres solubles a base de cyclodextrine(s) et/ou de derives de cyclodextrine(s)
|
|
AUPP868599A0
(en)
|
1999-02-15 |
1999-03-11 |
Novogen Research Pty Ltd |
Production of isoflavone derivatives
|
|
AUPQ008299A0
(en)
|
1999-04-30 |
1999-05-27 |
G.J. Consultants Pty Ltd |
Isoflavone metabolites
|
|
WO2001007031A1
(en)
|
1999-07-26 |
2001-02-01 |
Shionogi & Co., Ltd. |
Benzene derivatives and immunopotentiating compositions or drug-sensitivity restoring agents containing the same
|
|
AUPQ266199A0
(en)
|
1999-09-06 |
1999-09-30 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods involving isoflavones and analogues thereof
|
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
|
WO2001026651A2
(en)
|
1999-10-14 |
2001-04-19 |
Endorecherche, Inc. |
Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance
|
|
WO2001042233A1
(en)
|
1999-12-13 |
2001-06-14 |
Chugai Seiyaku Kabushiki Kaisha |
Optically active chroman and thiochroman derivatives
|
|
US6479467B1
(en)
|
1999-12-16 |
2002-11-12 |
Eastman Chemical Company |
Cyclodextrin ethers
|
|
AU2991301A
(en)
|
2000-01-28 |
2001-08-07 |
Endorecherche Inc. |
Selective estrogen receptor modulators in combination with estrogens
|
|
DE60117777T2
(de)
|
2000-05-11 |
2006-08-17 |
Eastman Chemical Co., Kingsport |
Acylierte zyclodextrin guest-inklusion komplexe
|
|
FI20001593A7
(fi)
|
2000-07-03 |
2002-01-04 |
Orion Yhtymo Oyj |
Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
|
|
CN1250505C
(zh)
|
2000-08-31 |
2006-04-12 |
科学工业研究院 |
制备1－丙基－2，4，5－三甲氧基苯的改进方法
|
|
AU2002241823A1
(en)
|
2001-01-11 |
2002-07-24 |
Eastman Chemical Company |
Cyclodextrin sulfonates, guest inclusion complexes, methods of making the same and related materials
|
|
NZ527144A
(en)
|
2001-01-24 |
2005-03-24 |
Chiesi Farmaceutici S |
2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
|
|
JP4313041B2
(ja)
|
2001-02-14 |
2009-08-12 |
ナームローゼ・フエンノートチヤツプ・オルガノン |
２−アルキル化−シクロデキストリン誘導体：薬物性神経筋遮断に対する拮抗薬
|
|
JP2005528320A
(ja)
|
2001-08-11 |
2005-09-22 |
ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー |
選択的なエストロゲン受容体モジュレーター
|
|
KR20040048407A
(ko)
|
2001-09-06 |
2004-06-09 |
시녹스, 인크. |
3-데옥시플라보노이드에 의한 ｔ-림프구 활성화의 억제 및그의 관련 치료법
|
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
|
WO2003063859A1
(en)
|
2002-01-14 |
2003-08-07 |
Nordic Bioscience A/S |
Suppression of cartilage degradation via the estrogen receptor
|
|
MXPA04009896A
(es)
|
2002-04-09 |
2005-06-17 |
Novogen Res Pty Ltd |
Metodos terapeuticos y composiciones que implican estructuras de tipo isoflav-3-eno e isoflavano.
|
|
AU2002951833A0
(en)
|
2002-10-02 |
2002-10-24 |
Novogen Research Pty Ltd |
Compositions and therapeutic methods invloving platinum complexes
|
|
CN1717209A
(zh)
|
2002-10-09 |
2006-01-04 |
植入疗法公司 |
以环糊精为基础的材料、其相关的组合物和用途
|
|
WO2005049627A1
(en)
|
2003-11-18 |
2005-06-02 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
|
CN101123958A
(zh)
|
2003-11-19 |
2008-02-13 |
诺沃根研究股份有限公司 |
联合放射疗法与化学疗法的组合物和方法
|
|
DE102004002787A1
(de)
|
2004-01-19 |
2005-08-11 |
Merck Patent Gmbh |
Flavonoid-Komplexe
|
|
JP4976649B2
(ja)
|
2004-09-21 |
2012-07-18 |
マーシャル エドワーズ，インク． |
化合物
|
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
EP1809618B1
(en)
|
2004-09-21 |
2013-07-17 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
ATE532777T1
(de)
|
2004-09-21 |
2011-11-15 |
Marshall Edwards Inc |
Substituierte chromanderivate, medikamente und anwendungen in der therapie
|
|
JP4913056B2
(ja)
|
2004-09-21 |
2012-04-11 |
マーシャル エドワーズ，インコーポレーテッド |
置換クロマン誘導体、医薬品、および治療における使用
|
|
WO2008052256A1
(en)
|
2006-10-30 |
2008-05-08 |
Novogen Research Pty Ltd |
Prevention and reversal of chemotherapy-induced peripheral neuropathy
|
|
WO2008113100A1
(en)
|
2007-03-16 |
2008-09-25 |
Novogen Research Pty Ltd |
Method for inducing autophagy
|
|
US20120039917A1
(en)
|
2008-08-29 |
2012-02-16 |
Alan James Husband |
Immunomodulating activities
|
|
CA2641541A1
(en)
|
2008-10-22 |
2010-04-22 |
Novogen Research Pty Ltd. |
Methods for inducing programmed cell death
|
|
CN102596196A
(zh)
|
2008-10-22 |
2012-07-18 |
诺沃根研究控股有限公司 |
用于诱导程序性细胞死亡的方法
|
|
US9663484B2
(en)
|
2010-11-01 |
2017-05-30 |
Mei Pharma, Inc. |
Isoflavonoid compounds and methods for the treatment of cancer
|
|
US20120251630A1
(en)
*
|
2011-03-29 |
2012-10-04 |
Marshall Edwards, Inc. |
Remission therapy of cancer with isoflavonoids
|
|
JP2015532272A
(ja)
|
2012-09-28 |
2015-11-09 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
二重アンジオポエチン−２／Ｄｌｌ４結合剤および抗ＶＥＧＦ−Ｒ剤を含む薬学的組み合わせ
|
|
SG11201604490SA
(en)
|
2014-02-07 |
2016-07-28 |
Novogen ltd |
Functionalised benzopyran compounds and use thereof
|
|
CN107427003B
(zh)
*
|
2015-02-02 |
2023-01-31 |
梅制药公司 |
联合治疗
|